Clinical Insights in Geriatrics: Managing Pain in Older Adults with Cognitive Impairment
Release Date: December-06-11
Credit Expiration Date: December-06-12
Senior care providers including primary care physicians, long-term care physicians, nurses, consultant pharmacists, and others interested in the care of older patients with chronic pain.
Family Physicians: 0.5 Prescribed credit
Nurses: 0.5 Contact Hours
Pharmacists: 0.5 Contact Hour (0.05 CEU)
A significant majority of older adults experience pain that may interfere with normal functioning. The ramifications of this extend far beyond the pain itself, increasing the risk of depression, care complexity, sleep problems, and hospitalization, as well as reducing patient quality of life and increasing overall costs. Numerous barriers interfere with the ability of clinicians to provide adequate pain management for seniors, including regulatory and reimbursement issues, patient comorbidities, concern about side effects, and the cognitive issues and dementia many of these patients experience.
Despite significant advances in drug development, pain remains inadequately managed in older adults. Furthermore, diagnosing and properly managing patients with cognitive impairment is even more challenging. Primary care providers and other senior care clinicians must be up-to-date on the most effective ways to assess and monitor pain in patients with cognitive impairment.
Michael R. Clark, MD, MPH, MBA
Department of Psychiatry and Behavioral Sciences
The Johns Hopkins Hospital
Patricia Bruckenthal, PhD, APRN-BC, ANP
Chair and Clinical Associate Professor
Department of Graduate Studies in Advanced Practice Nursing
Stony Brook University School of Nursing
Stony Brook, NY
Lori Reisner, PharmD, FCSHP
Neurological Surgery Department of Pharmaceutical Services
Clinical Professor of Pharmacy,
Department of Clinical Pharmacy
School of Pharmacy University of California
San Francisco Medical Center
San Francisco, CA
Lowell Kleinman, MD
San Clemente, CA
It is the policy of the AAFP, ASCP, and NADONA to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Dr. Clark discloses the following: Consultant: Eli Lilly & Company.
Dr. Bruckenthal discloses the following: Consultant: Cephalon, Inc., Endo Pharmaceuticals, and Ameritox Ltd.
Dr. Reisner has no relevant financial conflicts to disclose.
Dr. Kleinman has no relevant financial conflicts to disclose.
Ms. Dechevalier has no relevant financial conflicts to disclose.
Dr. Gerber has no relevant financial conflicts to disclose.
Ms. Barrett has no relevant financial conflicts to disclose.
Ms. Dornberger has no relevant financial conflicts to disclose.
Dr. Thier has no relevant financial conflicts to disclose.
Dr. Paczolt has no relevant financial conflicts to disclose.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This Enduring Material activity, Managing Pain in Older Adults with Cognitive Impairment, has been reviewed and is acceptable for up to 0.50 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins December 6, 2011. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This knowledge-based activity, ACPE Universal Activity #0203-9999-11-162-H01-P, has been assigned 0.5 Contact Hour (0.05 CEU).
NADONA/LTC is an approved provider of continuing nursing education by Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation #1088. This activity provides 0.5 contact hour by NADONA/LTC.
Participants must view the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing pharmacy education credit. Credit will be awarded for a score of 80% or better, and a statement may be printed immediately after passing the post-test.
There is no fee to participate in this educational activity.
This activity is supported in part by an educational grant from Purdue Pharma.
This activity is supported in part by an educational grant from Pfizer Inc.
© 2011, Medical Communications Media, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, ASCP, NJAFP, NADONA, Purdue Pharma, or Pfizer Inc. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.